Ternary Health
Featured condition · Dercum's

Dercum's Disease

A rare disorder of multiple painful subcutaneous lipomas — misdiagnosed as obesity, fibromyalgia, or 'stress' for years on average. The sister condition to Madelung's Disease in the adipose-disorder family.

Overview

What we mean when we say Dercum's.

Dercum's disease — also called adiposis dolorosa — is a rare disorder characterized by multiple painful lipomatous growths in subcutaneous tissue, typically across the trunk, upper arms, thighs, and forearms. Onset is most common between 35 and 50, and the condition affects women far more often than men.

Unlike ordinary adipose tissue, Dercum's lipomas are painful, do not respond predictably to weight loss, and tend to progress over time. The literature distinguishes four subtypes — juxta-articular, diffuse, nodular, and mixed — distinctions that carry real implications for surgical and non-surgical management.

Dercum's shares tissue-level pathology with Madelung's Disease and lipedema, and often overlaps with metabolic dysfunction, sleep-disordered breathing, and connective-tissue differences. The integrated picture is rarely assembled in routine care.

Why it’s hard to navigate

The pattern we see in Dercum's cases.

Signals we look for

The Ternary Signal Library for Dercum's.

Our Signal Library codifies the specific patterns that matter in Dercum's — labs, genetic variants, imaging findings, symptom clusters, and comorbidity combinations. Your case is mapped against these signals in Stage 4 of the workflow; each activated signal is weighted and prioritized for your presentation.

Pain pattern & distribution
  • Subtype classification — juxta-articular / diffuse / nodular / mixed
  • Anatomic mapping — trunk, arms, thighs, forearms
  • Pain character — burning / aching / pressure-sensitive
  • Pain triggers — pressure, temperature, menstrual cycle
  • Functional impact — mobility, sleep, daily activities
Laboratory markers
  • Inflammatory markers — CRP, ESR
  • Thyroid panel — TSH, free T4, antibodies
  • Metabolic panel — fasting insulin, A1c, lipids
  • Hormone panel — estrogen, progesterone, cortisol
  • Vitamin D, B12, magnesium — correctable deficiencies
Imaging & structural
  • Targeted ultrasound of painful regions
  • Whole-body MRI when distribution is ambiguous
  • DEXA body composition if metabolic overlap suspected
  • Connective-tissue assessment (Beighton, skin findings)
Comorbidity patterns
  • Sleep apnea / disordered breathing
  • Hypermobility / connective-tissue features
  • Venous or lymphatic dysfunction
  • Autoimmune or inflammatory conditions
  • Prior liposuction and recurrence history
How we approach it

The Ternary Health approach to Dercum's.

01

Review distribution, subtype, pain pattern, and associated findings against published Dercum's frameworks — then classify where the data supports it.

02

Integrate metabolic workup, sleep studies, connective-tissue assessment, and imaging into a single view rather than a stack of isolated consults.

03

Map pain-management options — medication, procedural, lifestyle — with evidence grading per strategy, so the trade-offs are visible, not hidden.

04

Surgical and non-surgical decision support — including identification of the short list of global specialists with Dercum's-specific experience.

The nine-stage workflow, applied

How a Dercum's case moves through our workflow.

Our nine-stage workflow is the same for every engagement. What changes per condition is the content at each stage — the records we pull, the signals we apply, the specialists we map, the pathways we evaluate. Below, how your case specifically would move through each stage.

Stage 01 · Days 0–2
Qualification
Fit screen focuses on diagnosed or strongly suspected Dercum's, functional impact of pain, and interest in structured evaluation beyond standard primary-care management.
Stage 02 · Days 3–7
Intake & data aggregation
Records pull emphasizes prior pain workup, imaging, metabolic labs, and any adipose-specialist consultation notes. Pain history captured as a trajectory, not a snapshot.
Stage 03 · Days 7–9
Case structuring
Case schema populated. Subtype (juxta-articular / diffuse / nodular / mixed) evaluated from records and imaging. Distribution mapped anatomically. Pain pattern coded.
Stage 04 · Days 9–12
Signal analysis
Ternary Signal Library for Dercum's applied — pain pattern, metabolic axis, connective-tissue axis, and comorbidity cluster signals weighted against your presentation.
Stage 05 · Days 10–14
Evidence retrieval
Literature scan across pain-management, adipose-disorder, and metabolic pathways. Evidence on low-dose naltrexone, IV lidocaine, deoxycholic acid, and surgical debulking refreshed per engagement.
Stage 06 · Days 14–17
Pathway mapping
Pathway map built across pharmacologic pain management, procedural (DCA, targeted surgery), surgical (tumescent liposuction with adipose-disorder-aware surgeons), lifestyle, and monitoring.
Stage 07 · Days 17–20
Synthesis & plan construction
Interventions scored on the Ternary Method. Sequencing typically: establish deficiency corrections and comorbidity management before surgical decisions; pain management in parallel.
Stage 08 · Days 20–25
Delivery & calibration
Findings call emphasizes the realistic trajectory — Dercum's is not curable with current medicine; what changes is the rate of progression and the quality of management.
Stage 09 · Days 25–55
Execution support
30 days of asynchronous follow-up through pain-specialist consultations, adipose-disorder specialist outreach, and any procedural decisions.
Deliverables

What you receive.

  • A written case synthesis with subtype classification
  • Integrated view of pain pattern, metabolic status, and co-occurring features
  • Evidence-graded pain-management framework
  • Surgical and non-surgical decision support
  • Specialist identification with Dercum's-specific experience
  • A written action plan and follow-up support as you implement it
Common questions — Dercum's

What prospective Dercum's clients ask most.

Is Dercum's pain manageable without surgery?
For many clients, yes. We map evidence-graded pharmacologic options (low-dose naltrexone, IV lidocaine protocols, targeted injectables) against your pain pattern and subtype. Surgery is one option among several, not always the right first move.
How do I know which Dercum's subtype I have?
Subtype classification — juxta-articular, diffuse, nodular, or mixed — comes from distribution, imaging, and clinical exam. As part of Stage 3 case structuring, we map the distribution from your records and propose a working subtype for discussion with a Dercum's-familiar specialist.
Will you coordinate with a Dercum's specialist for me?
We don't make direct referrals or manage appointments. What we do is identify specialists with Dercum's-specific experience, prepare pre-visit briefing materials for you, and help you evaluate what they recommend afterward.
What if I've never had adipose imaging?
Typical initial imaging — targeted ultrasound of painful regions, and whole-body MRI if distribution is ambiguous — is part of what we'd identify as a gap in Stage 5. Getting those studies done is one of the common early priorities in a Dercum's engagement.
Can I apply before getting a formal diagnosis?
Yes. Suspected Dercum's is a reasonable basis for applying. Part of our work would be evaluating the evidence for and against the diagnosis against your records and pattern, and helping you pursue clarification with the right specialist.

Ready for a case review?

Applications are reviewed within three business days.